Professor Lu Ming: Sofantinib combined with teriprizumab in the treatment of neuroendocrine cancer
Time of Update: 2021-12-06
The recent 2021 North American Society of Neuroendocrine Oncology (NANETS) annual meeting announced the latest data from the Phase II clinical study of sofatinib combined with teriprizumab in the treatment of advanced neuroendocrine cancer that failed first-line chemotherapy .
Home-made cervical cancer vaccine won the international "passport"
Time of Update: 2021-12-05
Breaking through the "99% bottleneck"-the domestic cervical cancer vaccine won the international "pass" October 14, 2021 is a memorable day, by the Xiamen University Xia Ningshao team and Yangshengtang Wantai Biotech's Xiamen The first domestic cervical cancer vaccine "Xinkening" jointly developed by Wantai Canghai Biotechnology Co.
ATA International Conference: Thyroid-related "radioiodine therapy" may cause cancer concerns
Time of Update: 2021-11-16
Introduction: A research report published at the annual meeting of the American Thyroid Association in 2021 showed that compared with young people who did not receive radioactive iodine therapy (RAI), young people who received RAI had a 92% increase in the risk of leukemia and solid malignant tumors.
the therapeutic window of antibody-conjugated drugs (ADC) at the 33rd International Conference on Molecular Targets and Cancer Therapy
Time of Update: 2021-11-05
Based on the innovative technology platform, Pufang Bio has developed a series of product pipelines composed of drug candidates targeting solid tumor targets.
Drug Y officially landed in Jiahui International Cancer Center and became a pioneer in the use of dual immunotherapy in China
Time of Update: 2021-10-21
Shanghai, October 12, 2021/PRNewswire/ - On June 10, 2021, the first CTLA-4 inhibitor ipilimumab in China was approved by the China National Medical Products Administration (NMPA) to join Navuriu Mono
Ann Intern Med: The risk of recurrence after incomplete resection of colorectal cancer polyps
Time of Update: 2021-10-10
The risk of metachronous tumors in bowel segments with incomplete polyps resection was significantly higher than that in bowel segments with complete polyps removal (52% vs 23%; poor risk [RD] 28%, 95% CI 9%-47%; p= 0.
CStone Pharmaceuticals announces CS5001 (ROR1 ADC) research data at the 33rd International Conference on Molecular Targets and Cancer Therapy in 2021
Time of Update: 2021-10-10
Suzhou, China, October 8, 2021/PRNewswire/ - CStone Pharmaceuticals (Hong Kong Stock Exchange code: 2616), a leading biopharmaceutical company focusing on research, development and commercialization o
[Nature Sub-Journal] The 3D pancreatic cancer tumor model cultivated by an international team
Time of Update: 2021-09-30
In a new study published in "Nature Communications" on September 24, researchers from the University of Nottingham, Queen Mary University of London, Monash University and Shanghai Jiaotong University created a multicellular three-dimensional microenvironment that uses patient sources The cells reproduce the growth pattern of tumor cells in pancreatic cancer and respond to chemotherapy drugs .
International innovative lung cancer drug completes its first clinical use in China
Time of Update: 2021-09-28
, after a rigorous evaluation of the patient’s condition by the team of Professor Wang Meiqing, Department of Oncology, Hainan Provincial Tumor Hospital, on September 14, 2021, one KRAS G12C mutation non-small cell lung cancer patients in the Boao Super Hospital in the Lecheng pilot area of Hainan successfully took the world's first innovative drug LUMAKRAS for the treatment of KRAS G12C mutations in non-small cell lung cancer .
and disease-free survival of rectal cancer: results from the international TaTME registration study
Time of Update: 2021-09-12
Therefore, the research team from the United Kingdom carried out related studies with the purpose of expanding the sample size to evaluate the safety of TaTME in patients with primary rectal cancer, mainly from LR, disease-free survival (DFS) and overall survival (OS), etc.
International Agency for Research on Cancer: The number of cancer patients doubles in the next 50
Time of Update: 2021-09-05
The article pointed out that if the current trend is to develop, the annual new cancer cases will reach 34 million by 2070, which is double the data in 2020; and in the comprehensive cancer prevention strategy, the main cancer risk factors, such as smoking and overweight Obesity and high-risk human papillomavirus (HPV) infection will be the top priority for prevention and control .
Overcoming international problems, a large-scale study by Chinese scholars is the first
Time of Update: 2021-08-29
The reporter learned on the 11th that the large-scale research conducted by the team of Professor Chen Haiquan of Thoracic Surgery of Fudan University Cancer Hospital has taken the lead in clearly defining the scope of lymph node dissection for esophageal cancer in the international academic community .
International Agency for Research on Cancer: Attention!
Time of Update: 2021-08-26
Researchers obtained colon cancer and rectal cancer incidence data from 20 population-based cancer registries in Australia, Canada, Denmark, Norway, New Zealand, Ireland, and the United Kingdom , and used an age-period-cohort model to assess each age Incidence trends in groups, periods, and birth cohorts .
Ann Intern Med: How to screen for colorectal cancer more accurately through stool?
Time of Update: 2021-08-03
The difference in abundance of 9 protein biomarkers in 1284 FIT samplesThe difference in abundance of 9 protein biomarkers in 1284 FIT samplesCART analysis showed that the cross-validation sensitivity of binding hemoglobin, calprotectin, and serpin family member 2-mtFIT-to high-grade neoplasms was 42.
International Agency for Research on Cancer: More than 740,000 new cancer cases in 2020 are related to alcohol use
Time of Update: 2021-08-02
The report also quantifies the proportion of new cancer cases associated with various levels of alcohol consumption and shows that even light to moderate drinking can have a significant impact on cancer .